Skip to content
★ Sign in to follow
CA

Cormorant Asset Management, LLC

Related company / holding
Total declarations
24
Companies
2
▲ Purchases (22 ops.)
€26.1M
▼ Sales (1 ops.)
€2.1M

Latest filing published 18 Dec 2017 for Kineta, Inc./de, €2.1M.

Filing timeline

BuySale
Cormorant Asset Management, LLC

Insider track record

Disclosed buys
22
Disclosed sells
1
Signal history

Closed purchases

Market purchases
22

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Cormorant Asset Management, LLC: trading record in brief

Cormorant Asset Management, LLC is a declared insider at 2 companies; the most frequent names are Kineta, Inc./de and Apellis Pharmaceuticals, Inc. The record holds 24 filings, for trades running from 3 November 2016 to 14 December 2017.

On the open market, the record shows 22 purchases worth €26.1M and 1 sale worth €2.1M. Taken together, the purchases exceed the sales by €24.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2017, the count stands at 1 purchase and 1 sale.

The median purchase comes to €352k. Clusters matter here: 1 out of 22 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 18 December 2017, reports an open-market sale of €2.1M in Kineta, Inc./de. The latest purchase dates back some time: it was published 3,282 days ago, on 14 November 2017. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Cormorant Asset Management, LLC

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations